T3	Condition 164 180	plaque psoriasis
T4	Condition-Name 164 180	plaque psoriasis
E3	Condition:T3 Name:T4
T5	Condition 192 208	plaque psoriasis
T6	Condition-Name 192 208	plaque psoriasis
E5	Condition:T5 Name:T6 Stability:T1 Duration:E1
T8	Procedure 297 313	systemic therapy
T9	Procedure-Name 297 313	systemic therapy
E8	Procedure:T8 Name:T9
T10	Procedure 281 293	phototherapy
T11	Procedure-Name 281 293	phototherapy
E10	Procedure:T10 Name:T11
T18	Eq-Temporal-Unit 224 230	months
A1	Eq-Temporal-Unit-Value T18 month
T19	Eq-Value 222 223	6
T1	Stability 185 191	Stable
A2	Stability-Value T1 stable
T2	Eq-Comparison 213 230	at least 6 months
E1	Eq-Comparison:T2 Operator:T21 Temporal-Unit:T18 Value:T19
T21	Eq-Operator 213 221	at least
A3	Eq-Operator-Value T21 GTEQ
T7	Coreference 254 261	disease
E2	Coreference:T7 Refers-To:E5
T22	Severity 247 253	severe
A4	Severity-Value T22 severe
T23	Severity 235 243	Moderate
A5	Severity-Value T23 severe
T25	Condition 254 261	disease
E4	Condition:T25 Severity:T22
T26	Indication 267 276	Candidate
E6	Indication:T26 Indication-For:E10
T27	Or 294 296	or
E9	Or:T27 Arg:E10 Arg2:E8
T12	Condition 390 409	psoriatic arthritis
E11	Condition:T12 Name:T13
T13	Condition-Name 390 409	psoriatic arthritis
T14	Condition 411 434	erythrodermic psoriasis
E12	Condition:T14 Name:T15
T15	Condition-Name 411 434	erythrodermic psoriasis
T16	Condition 439 469	generalized pustular psoriasis
E13	Condition:T16 Name:T17
T17	Condition-Name 439 469	generalized pustular psoriasis
T28	Or 436 438	or
E14	Or:T28 Arg:E12 Arg2:E13
T29	Condition 529 538	psoriasis
E15	Condition:T29 Name:T30
T30	Condition-Name 529 538	psoriasis
T31	Modifier 516 528	drug-induced
E16	Modifier:T31 Modifies:T30
T32	Modifier 504 511	inverse
E17	Modifier:T32 Modifies:T30
T33	Modifier 495 502	Guttate
E18	Modifier:T33 Modifies:T30
T34	Or 513 515	or
E19	Or:T34 Arg:E17 Arg2:E16
T35	Study 542 551	Screening
E20	Study:T35 
T36	Study 555 563	Baseline
E21	Study:T36 
T37	Or 552 554	or
E22	Or:T37 Arg:E20 Arg2:E21
T38	Temporal-Connection 539 541	at
E23	Temporal-Connection:T38 Arg:E15 Arg2:E20
A6	Temporal-Connection-Type-Value E23 during
T39	Condition 587 596	infection
E24	Condition:T39 Name:T40 Temporality:E25 Temporality2:E27
T40	Condition-Name 587 596	infection
T41	Eq-Comparison 580 586	recent
E25	Eq-Comparison:T41 Temporal-Period:T42
T42	Eq-Temporal-Period 580 586	recent
A7	Eq-Temporal-Period-Value T42 recent
T20	Drug 620 630	BMS-986165
E26	Drug:T20 Name:T43 Temporality:E28
T43	Drug-Name 620 630	BMS-986165
T44	Eq-Comparison 569 576	History
E27	Eq-Comparison:T44 Temporal-Period:T45
T45	Eq-Temporal-Period 569 576	History
A8	Eq-Temporal-Period-Value T45 past
T46	Eq-Comparison 602 607	Prior
E28	Eq-Comparison:T46 Temporal-Period:T47
T47	Eq-Temporal-Period 602 607	Prior
A9	Eq-Temporal-Period-Value T47 past
T24	Eq-Comparison 235 253	Moderate to severe
E7	Eq-Comparison:T24 Value:T23 Value2:T22 Operator:T48
T48	Eq-Operator 244 246	to
A10	Eq-Operator-Value T48 BETWEEN
